Capricor Therapeutics raised to Buy from Neutral by B. Riley
B. Riley Securities upgraded Capricor Therapeutics from Neutral to Buy, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.